Signal Transduction and Targeted Therapy (Mar 2023)

Pathogenesis of allergic diseases and implications for therapeutic interventions

  • Ji Wang,
  • Yumei Zhou,
  • Honglei Zhang,
  • Linhan Hu,
  • Juntong Liu,
  • Lei Wang,
  • Tianyi Wang,
  • Haiyun Zhang,
  • Linpeng Cong,
  • Qi Wang

DOI
https://doi.org/10.1038/s41392-023-01344-4
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 30

Abstract

Read online

Abstract Allergic diseases such as allergic rhinitis (AR), allergic asthma (AAS), atopic dermatitis (AD), food allergy (FA), and eczema are systemic diseases caused by an impaired immune system. Accompanied by high recurrence rates, the steadily rising incidence rates of these diseases are attracting increasing attention. The pathogenesis of allergic diseases is complex and involves many factors, including maternal-fetal environment, living environment, genetics, epigenetics, and the body’s immune status. The pathogenesis of allergic diseases exhibits a marked heterogeneity, with phenotype and endotype defining visible features and associated molecular mechanisms, respectively. With the rapid development of immunology, molecular biology, and biotechnology, many new biological drugs have been designed for the treatment of allergic diseases, including anti-immunoglobulin E (IgE), anti-interleukin (IL)-5, and anti-thymic stromal lymphopoietin (TSLP)/IL-4, to control symptoms. For doctors and scientists, it is becoming more and more important to understand the influencing factors, pathogenesis, and treatment progress of allergic diseases. This review aimed to assess the epidemiology, pathogenesis, and therapeutic interventions of allergic diseases, including AR, AAS, AD, and FA. We hope to help doctors and scientists understand allergic diseases systematically.